Fidelity International’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-666,891
| Closed | -$7.49M | – | 673 |
|
|
2018
Q1 | $7.49M | Hold |
666,891
| – | – | 0.02% | 376 |
|
|
2017
Q4 | $4.46M | Hold |
666,891
| – | – | 0.01% | 420 |
|
|
2017
Q3 | $5.46M | Sell |
666,891
-86,850
| -12% | -$711K | 0.02% | 391 |
|
|
2017
Q2 | $3.38M | Hold |
753,741
| – | – | 0.01% | 416 |
|
|
2017
Q1 | $4.15M | Hold |
753,741
| – | – | 0.01% | 420 |
|
|
2016
Q4 | $3.05M | Buy |
753,741
+1
| +0% | +$4 | 0.01% | 432 |
|
|
2016
Q3 | $5.31M | Hold |
753,740
| – | – | 0.02% | 385 |
|
|
2016
Q2 | $6.14M | Hold |
753,740
| – | – | 0.02% | 367 |
|
|
2016
Q1 | $6.13M | Hold |
753,740
| – | – | 0.02% | 363 |
|
|
2015
Q4 | $9.09M | Buy |
753,740
+666,891
| +768% | +$8.04M | 0.03% | 336 |
|
|
2015
Q3 | $1.04M | Hold |
86,849
| – | – | ﹤0.01% | 476 |
|
|
2015
Q2 | $1.59M | Buy |
+86,849
| New | +$1.59M | 0.01% | 489 |
|